Use of inotropes and vasopressor agents in critically ill patients

被引：111

作者：

Bangash, Mansoor N. ^{[1
]}

Kong, Ming-Li ^{[1
]}

Pearse, Rupert M. ^{[1
]}

机构：

[1] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London, England

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2012年 / 165卷 / 07期

关键词：

inotrope; vasopressor; critical illness; haemodynamic shock; CONTRAST-INDUCED NEPHROPATHY; PULMONARY-ARTERY CATHETERS; ORIENTED HEMODYNAMIC THERAPY; MAXIMIZING OXYGEN DELIVERY; BETA-ADRENERGIC RECEPTORS; STANDARD-DOSE EPINEPHRINE; RANDOMIZED CLINICAL-TRIAL; GOAL-DIRECTED THERAPY; TUMOR-NECROSIS-FACTOR; REGIONAL BLOOD-FLOW;

D O I：

10.1111/j.1476-5381.2011.01588.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Inotropes and vasopressors are biologically and clinically important compounds that originate from different pharmacological groups and act at some of the most fundamental receptor and signal transduction systems in the body. More than 20 such agents are in common clinical use, yet few reviews of their pharmacology exist outside of physiology and pharmacology textbooks. Despite widespread use in critically ill patients, understanding of the clinical effects of these drugs in pathological states is poor. The purpose of this article is to describe the pharmacology and clinical applications of inotropic and vasopressor agents in critically ill patients.

引用

页码：2015 / 2033

页数：19

共 50 条

[21] Use of Colistin in Critically Ill Patients
Marchaim, Dror
Kaye, Donald
Kaye, Keith S.
[J]. POLYMYXIN ANTIBIOTICS: FROM LABORATORY BENCH TO BEDSIDE, 2019, 1145 : 155 - 179
[22] Comparison between invasive and noninvasive blood pressure measurements in critically ill patients receiving inotropes
Kaur, Babandeep
Kaur, Sukhpal
Yaddanapudi, Lakshmi N.
Singh, Neena V.
[J]. BLOOD PRESSURE MONITORING, 2019, 24 (01) : 24 - 29
[23] Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus
Carsetti, Andrea
Bignami, Elena
Cortegiani, Andrea
Donadello, Katia
Donati, Abele
Foti, Giuseppe
Grasselli, Giacomo
Romagnoli, Stefano
Antonelli, Massimo
De Blasio, Elvio
Forfori, Francesco
Guarracino, Fabio
Scolletta, Sabino
Tritapepe, Luigi
Scudeller, Luigia
Cecconi, Maurizio
Girardis, Massimo
[J]. MINERVA ANESTESIOLOGICA, 2021, 87 (06) : 714 - 732
[24] Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients
Mehta, S
Burry, L
Fischer, S
Martinez-Motta, JC
Hallett, D
Bowman, D
Wong, C
Meade, MO
Stewart, TE
Cook, DJ
[J]. CRITICAL CARE MEDICINE, 2006, 34 (02) : 374 - 380
[25] Tolerability and Safety of Enteral Nutrition in Critically Ill Patients Receiving Intravenous Vasopressor Therapy
Mancl, Erin E.
Muzevich, Katie M.
[J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2013, 37 (05) : 641 - 651
[26] Early versus late enteral nutrition in critically ill patients receiving vasopressor support
Dorken Gallastegi, Ander
Gebran, Anthony
Gaitanidis, Apostolos
Naar, Leon
Hwabejire, John O.
Parks, Jonathan
Lee, Jarone
Kaafarani, Haytham M. A.
Velmahos, George C.
Mendoza, April E.
[J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2022, 46 (01) : 130 - 140
[27] TOLERABILITY AND SAFETY OF ENTERAL NUTRITION IN CRITICALLY ILL PATIENTS RECEIVING INTRAVENOUS VASOPRESSOR THERAPY
Mancl, Erin
Muzevich, Katie
[J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U95 - U95
[28] Plasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients
Pea, Federico
[J]. CURRENT CLINICAL PHARMACOLOGY, 2013, 8 (01): : 5 - 12
[29] Review of Pharmacologic Sleep Agents for Critically Ill Patients
Marino, Kaylee
Goodberlet, Melanie
Cyrus, Patricia
[J]. CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2021, 33 (02) : 145 - 153
[30] New Drugs for Old Problems: Which Inotropes for Critically Ill Children?
Schindler, Ehrenfried
Yamamoto, Tomohiro
[J]. PEDIATRIC CRITICAL CARE MEDICINE, 2018, 19 (07) : 674 - 675

← 1 2 3 4 5 →